Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study.

Montano C, Taub MA, Jaffe A, Briem E, Feinberg JI, Trygvadottir R, Idrizi A, Runarsson A, Berndsen B, Gur RC, Moore TM, Perry RT, Fugman D, Sabunciyan S, Yolken RH, Hyde TM, Kleinman JE, Sobell JL, Pato CN, Pato MT, Go RC, Nimgaonkar V, Weinberger DR, Braff D, Gur RE, Fallin MD, Feinberg AP.

JAMA Psychiatry. 2016 May 1;73(5):506-14. doi: 10.1001/jamapsychiatry.2016.0144.

2.

Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.

Ghani M, Reitz C, Cheng R, Vardarajan BN, Jun G, Sato C, Naj A, Rajbhandary R, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith PA, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Lee JH, Schellenberg GD, St George-Hyslop P, Mayeux R, Rogaeva E; Alzheimer’s Disease Genetics Consortium.

JAMA Neurol. 2015 Nov;72(11):1313-23. doi: 10.1001/jamaneurol.2015.1700.

3.

Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.

Hohman TJ, Cooke-Bailey JN, Reitz C, Jun G, Naj A, Beecham GW, Liu Z, Carney RM, Vance JM, Cuccaro ML, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue MW, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hardy J, Hendrie HC, Hall KS, Goate AM, Lang R, Byrd GS, Kukull WA, Foroud TM, Farrer LA, Martin ER, Pericak-Vance MA, Schellenberg GD, Mayeux R, Haines JL, Thornton-Wells TA; Alzheimer Disease Genetics Consortium.

Alzheimers Dement. 2016 Mar;12(3):233-43. doi: 10.1016/j.jalz.2015.02.012. Epub 2015 Jun 16.

4.

Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.

Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H; Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group, Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM.

Cell. 2013 Aug 1;154(3):518-29. doi: 10.1016/j.cell.2013.06.049.

5.

Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.

Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RC, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Mayeux R; Alzheimer Disease Genetics Consortium.

JAMA. 2013 Apr 10;309(14):1483-92. doi: 10.1001/jama.2013.2973.

6.

Persistent infection with neurotropic herpes viruses and cognitive impairment.

Watson AM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, Bradford LD, Calkins ME, Richard J, Edwards N, Savage RM, Allen TB, Kwentus J, McEvoy JP, Santos AB, Wiener HW, Go RC, Perry RT, Nasrallah HA, Gur RE, Devlin B, Nimgaonkar VL.

Psychol Med. 2013 May;43(5):1023-31. doi: 10.1017/S003329171200195X. Epub 2012 Sep 14.

PMID:
22975221
7.

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.

Bamne M, Wood J, Chowdari K, Watson AM, Celik C, Mansour H, Klei L, Gur RC, Bradford LD, Calkins ME, Santos AB, Edwards N, Kwentus J, McEvoy JP, Allen TB, Savage RM, Nasrallah HA, Gur RE, Perry RT, Go RC, Devlin B, Yolken R, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1149-54. doi: 10.1093/schbul/sbs087. Epub 2012 Sep 10.

8.

Heritability of functioning in families with schizophrenia in relation to neurocognition.

Savage RM, Wiener HW, Nimgaonkar V, Devlin B, Calkins ME, Gur RE, O'Jile J, Bradford LD, Edwards N, Kwentus J, Allen T, McEvoy JP, Nasrallah H, Santos AB, Aduroja T, Lahti A, May RS, Montgomery-Barefield L, Go RC.

Schizophr Res. 2012 Aug;139(1-3):105-9. doi: 10.1016/j.schres.2012.04.015. Epub 2012 May 23.

PMID:
22627125
9.

Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases.

Kennedy RE, Howard G, Go RC, Rothwell PM, Tiwari HK, Feng R, McClure LA, Prineas RJ, Banerjee A, Arnett DK.

Stroke. 2012 Apr;43(4):974-9. doi: 10.1161/STROKEAHA.111.645044. Epub 2012 Feb 9.

10.

Comparison of measures of marker informativeness for ancestry and admixture mapping.

Ding L, Wiener H, Abebe T, Altaye M, Go RC, Kercsmar C, Grabowski G, Martin LJ, Khurana Hershey GK, Chakorborty R, Baye TM.

BMC Genomics. 2011 Dec 20;12:622. doi: 10.1186/1471-2164-12-622.

11.

A comprehensive genetic association study of Alzheimer disease in African Americans.

Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RC, Griffith P, Obisesan TO, Shatz R, Borenstein A, Cupples LA, Lunetta KL, Fallin MD, Baldwin CT, Farrer LA; Multi-Institutional Research on Alzheimer Genetic Epidemiology (MIRAGE) Study Group.

Arch Neurol. 2011 Dec;68(12):1569-79. doi: 10.1001/archneurol.2011.646.

12.

Vascular risk factors and cognitive impairment in a stroke-free cohort.

Unverzagt FW, McClure LA, Wadley VG, Jenny NS, Go RC, Cushman M, Kissela BM, Kelley BJ, Kennedy R, Moy CS, Howard V, Howard G.

Neurology. 2011 Nov 8;77(19):1729-36. doi: 10.1212/WNL.0b013e318236ef23.

13.

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients.

Calkins ME, Tepper P, Gur RC, Ragland JD, Klei L, Wiener HW, Richard J, Savage RM, Allen TB, O'Jile J, Devlin B, Kwentus J, Aliyu MH, Bradford LD, Edwards N, Lyons PD, Nimgaonkar VL, Santos AB, Go RC, Gur RE.

Am J Psychiatry. 2010 Apr;167(4):459-72. doi: 10.1176/appi.ajp.2009.08091351. Epub 2010 Mar 1.

14.

Inhalational anaesthetics and n-alcohols share a site of action in the neuronal Shaw2 Kv channel.

Bhattacharji A, Klett N, Go RC, Covarrubias M.

Br J Pharmacol. 2010 Apr;159(7):1475-85. doi: 10.1111/j.1476-5381.2010.00642.x. Epub 2010 Feb 5.

15.

Association of higher diastolic blood pressure levels with cognitive impairment.

Tsivgoulis G, Alexandrov AV, Wadley VG, Unverzagt FW, Go RC, Moy CS, Kissela B, Howard G.

Neurology. 2009 Aug 25;73(8):589-95. doi: 10.1212/WNL.0b013e3181b38969.

16.

Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.

Irvin MR, Wiener HW, Perry RP, Savage RM, Go RC.

Schizophr Res. 2009 Oct;114(1-3):50-6. doi: 10.1016/j.schres.2009.07.008. Epub 2009 Jul 29.

17.

Linkage analysis of schizophrenia in African-American families.

Wiener HW, Klei L, Irvin MD, Perry RT, Aliyu MH, Allen TB, Bradford LD, Calkins ME, Devlin B, Edwards N, Gur RE, Gur RC, Kwentus J, Lyons PD, McEvoy JP, Nasrallah HA, Nimgaonkar VL, O'Jile J, Santos AB, Savage RM, Go RC.

Schizophr Res. 2009 Apr;109(1-3):70-9. doi: 10.1016/j.schres.2009.02.007. Epub 2009 Mar 5.

18.

Database mining for selection of SNP markers useful in admixture mapping.

Baye TM, Tiwari HK, Allison DB, Go RC.

BioData Min. 2009 Feb 14;2(1):1. doi: 10.1186/1756-0381-2-1.

19.

Altered functional properties of a TRPM2 variant in Guamanian ALS and PD.

Hermosura MC, Cui AM, Go RC, Davenport B, Shetler CM, Heizer JW, Schmitz C, Mocz G, Garruto RM, Perraud AL.

Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):18029-34. doi: 10.1073/pnas.0808218105. Epub 2008 Nov 12.

21.

Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles.

Koomoa DL, Go RC, Wester K, Bachmann AS.

Neurosci Lett. 2008 May 9;436(2):171-6. doi: 10.1016/j.neulet.2008.03.030. Epub 2008 Mar 15.

PMID:
18395978
22.

Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: the REasons for Geographic And Racial Differences in Stroke Study.

Voeks JH, McClure LA, Go RC, Prineas RJ, Cushman M, Kissela BM, Roseman JM.

Stroke. 2008 Jun;39(6):1675-80. doi: 10.1161/STROKEAHA.107.507053. Epub 2008 Apr 3.

23.

A genomic scan for age at onset of Alzheimer's disease in 437 families from the NIMH Genetic Initiative.

Dickson MR, Li J, Wiener HW, Perry RT, Blacker D, Bassett SS, Go RC.

Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):784-92. doi: 10.1002/ajmg.b.30689.

24.
25.

Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) With Alzheimer's disease.

Chen Z, Simmons MS, Perry RT, Wiener HW, Harrell LE, Go RC.

Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):363-9.

PMID:
17918233
26.

Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer's disease.

Li J, Cowden LG, King JD, Briles DA, Schroeder HW Jr, Stevens AB, Perry RT, Chen Z, Simmons MS, Wiener HW, Tiwari HK, Harrell LE, Go RC.

Psychosom Med. 2007 Jul-Aug;69(6):551-9. Epub 2007 Jul 18.

PMID:
17634568
27.

Knowledge of and attitudes about Alzheimer disease genetics: report of a pilot survey and two focus groups.

Moscarillo TJ, Holt H, Perman M, Goldberg S, Cortellini L, Stoler JM, DeJong W, Miles BJ, Albert MS, Go RC, Blacker D.

Community Genet. 2007;10(2):97-102.

PMID:
17380059
28.

A polymorphism in SOD2 is associated with development of Alzheimer's disease.

Wiener HW, Perry RT, Chen Z, Harrell LE, Go RC.

Genes Brain Behav. 2007 Nov;6(8):770-5. Epub 2007 Mar 21.

29.
30.

Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease.

Perry RT, Gearhart DA, Wiener HW, Harrell LE, Barton JC, Kutlar A, Kutlar F, Ozcan O, Go RC, Hill WD.

Neurobiol Aging. 2008 Feb;29(2):185-93. Epub 2006 Dec 8.

31.

Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort.

Perry RT, Wiener H, Harrell LE, Blacker D, Tanzi RE, Bertram L, Bassett SS, Go RC.

Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):220-7.

PMID:
17034007
32.

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods.

Aliyu MH, Calkins ME, Swanson CL Jr, Lyons PD, Savage RM, May R, Wiener H, McLeod-Bryant S, Nimgaonkar VL, Ragland JD, Gur RE, Gur RC, Bradford LD, Edwards N, Kwentus J, McEvoy JP, Santos AB, McCleod-Bryant S, Tennison C, Go RC, Allen TB; PAARTNERS Study Group.

Schizophr Res. 2006 Oct;87(1-3):32-44. Epub 2006 Aug 2. Erratum in: Schizophr Res. 2007 Feb;90(1-3):369. Allen, Trina B [added]; Devlin, Bernie [corrected to McLeod-Bryant, Stephen].

PMID:
16887335
33.

Further evidence of a maternal parent-of-origin effect on chromosome 10 in late-onset Alzheimer's disease.

Bassett SS, Avramopoulos D, Perry RT, Wiener H, Watson B Jr, Go RC, Fallin MD.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141B(5):537-40.

34.

Increased frequency of HLA-B44 in recurrent sinopulmonary infections (RESPI).

Johnston DT, Mehaffey G, Thomas J, Young KR Jr, Wiener H, Li J, Go RC, Schroeder HW Jr.

Clin Immunol. 2006 Jun;119(3):346-50. Epub 2006 Mar 20.

PMID:
16542878
35.

African-American community attitudes and perceptions toward schizophrenia and medical research: an exploratory study.

Hamilton LA, Aliyu MH, Lyons PD, May R, Swanson CL Jr, Savage R, Go RC.

J Natl Med Assoc. 2006 Jan;98(1):18-27.

36.

COGA phenotypes and linkages on chromosome 2.

Wiener HW, Go RC, Tiwari H, George V, Page GP.

BMC Genet. 2005 Dec 30;6 Suppl 1:S125.

37.

Association studies of transforming growth factor-beta 1 and Alzheimer's disease.

Dickson MR, Perry RT, Wiener H, Go RC.

Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):38-41.

PMID:
16082716
38.

Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.

Go RC, Perry RT, Wiener H, Bassett SS, Blacker D, Devlin B, Sweet RA.

Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):28-32.

PMID:
16082692
39.
40.

The reasons for geographic and racial differences in stroke study: objectives and design.

Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G.

Neuroepidemiology. 2005;25(3):135-43. Epub 2005 Jun 29.

PMID:
15990444
41.

Genetics and cardiovascular disease.

Acton RT, Go RC, Roseman JM.

Ethn Dis. 2004 Autumn;14(4):S2-8-16. Review.

PMID:
15724791
43.

Ancestry reported by white adults with cutaneous melanoma and control subjects in central Alabama.

Acton RT, Barton EH, Hollowell WW, Dreibelbis AL, Go RC, Barton JC.

BMC Cancer. 2004 Aug 13;4:47.

44.

"Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits.

Page GP, George V, Go RC, Page PZ, Allison DB.

Am J Hum Genet. 2003 Oct;73(4):711-9. Epub 2003 Sep 17. Review.

45.

Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin.

Saunders AJ, Bertram L, Mullin K, Sampson AJ, Latifzai K, Basu S, Jones J, Kinney D, MacKenzie-Ingano L, Yu S, Albert MS, Moscarillo TJ, Go RC, Bassett SS, Daly MJ, Laird NM, Wang X, Velicelebi G, Wagner SL, Becker DK, Tanzi RE, Blacker D.

Hum Mol Genet. 2003 Nov 1;12(21):2765-76. Epub 2003 Sep 9.

PMID:
12966032
46.

No association between marker D10S1423 and Alzheimer's disease.

Bertram L, Saunders AJ, Mullin K, Sampson A, Moscarillo TJ, Basset SS, Go RC, Blacker D, Tanzi RE.

Mol Psychiatry. 2003 Jun;8(6):571-3. No abstract available.

PMID:
12851634
47.

Results of a high-resolution genome screen of 437 Alzheimer's disease families.

Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE; NIMH Genetics Initiative Alzheimer's Disease Study Group.

Hum Mol Genet. 2003 Jan 1;12(1):23-32.

PMID:
12490529
48.

Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.

Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA.

Arch Neurol. 2002 Apr;59(4):594-600.

PMID:
11939894
49.

HFE mutations in African-American women with non-insulin-dependent diabetes mellitus.

Acton RT, Barton JC, Bell DS, Go RC, Roseman JM.

Ethn Dis. 2001 Fall;11(4):578-84.

PMID:
11763282
50.

The role of TNF and its receptors in Alzheimer's disease.

Perry RT, Collins JS, Wiener H, Acton R, Go RC.

Neurobiol Aging. 2001 Nov-Dec;22(6):873-83. Review.

PMID:
11754994

Supplemental Content

Support Center